Results 111 to 120 of about 18,615 (305)
Design and analysis strategies for robust microbiome ageing research
FEBS Letters, EarlyView.The gut microbiome changes with age and associates with age‐related morbidity and mortality, establishing it as a potential biomarker and intervention target for ageing. Realising this potential requires methodological rigour, yet distinguishing biological signals from methodological artefacts remains challenging across cohorts. This review provides an
Mark Olenik +5 more
wiley +1 more source
FEBS Letters, EarlyView.CT10 regulator of kinase (CRK) and CRK‐Like (CRKL) are signaling adaptors driving cell adhesion, motility, differentiation, and proliferation. SH2‐domain containing (SH) proteins are enriched in YXXP motifs which when phosphorylated create preferred binding sites for CRK family SH2 domains.
Phoebe M. Cousens +8 more
wiley +1 more source
, 2008 Sparks, Adam, Common Scab of Potato, Manhattan, Kansas, Kansas State University, May ...
Sparks, Adam Henry, Kennelly, Megan M.
core
The role of miR‐335‐5p in the redifferentiation of BRAF p.V600E thyroid cancers
Molecular Oncology, EarlyView.The BRAF p.V600E mutation promotes thyroid cancer dedifferentiation and radioiodine resistance. Using a network approach, we identified miR‐335‐5p as a key regulator of BRAF‐mutated thyroid tumors. Restoring miR‐335‐5p increased thyroid‐specific gene expression and iodine uptake in cells and organoids.
Valeria Pecce +11 more
wiley +1 more source
ECONOMIC IMPACTS OF FUSARIUM HEAD BLIGHT IN WHEAT
Fusarium Head Blight (FHB), commonly known as scab, has been a severe problem for wheat producers in recent years. This study estimates the economic value of crop losses suffered by wheat producers in the 1990s.
Johnson, D. Demcey +3 more
core
Common scab resistance in potato [PDF]
, 2016 Common scab disease of potato is distributed worldwide and not easily controlled. It is caused by Streptomyces species. The virulence mechanism of Streptomyces species is the production of thaxtomin A.
Ngo, Thach-Truc
core
Molecular Oncology, EarlyView.Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat +8 more
wiley +1 more source